Uncovering the role of KDM6A in epigenetic regulation of subtype plasticity in small cell lung cancer

by

In a new study published in Nature Cell Biology, researchers used CRISPR/Cas9 in vivo somatic engineering to make mouse models of small cell lung cancer (SCLC) that either expressed KDM6A (KDM6A-WT) or were inactivated for KDM6A (KDM6A-Mutant). KDM6A is an epigenetic modifier that is mutated in human SCLC.

Leave A Comment

Your email address will not be published. Required fields are marked *